Intermittent hypoxia and sleep fragmentation are critical pathophysiological 28 processes involved in obstructive sleep apnea/hypopnea syndrome (OSAHS). These 29 manifestation independently affect similar brain regions and contribute to 30 OSAHS-related comorbidities that are known to be related to the host gut alteration 31 microbiota. We hypothesized that microbiota disruption influences the 32 pathophysiological processes of OSAHS through a microbiota-gut-brain axis. Thus, 33 we aim to survey enterotypes and polysomnographic data of OSAHS patients. 34 Subjects were diagnosed by polysomnography, from whom fecal samples were 35 obtained and analyzed for the microbiome composition by variable regions 3-4 of 36 16S rRNA pyrosequencing and bioinformatic analyses. We examined blood 37 cytokines level of all subjects. Three enterotypes Bacteroides (n=73), Ruminococcus 38 (n=14), and Prevotella (n=26) were identified. Central apnea indices, mixed apnea 39 indices, N1 sleep stage, mean apnea-hypopnea duration, and arousal indices were 40 increased in apnea-hypopnea indices (AHI) ≥15 patients with the Prevotella 41 enterotype. However, for AHI<15 subjects, obstructive apnea indices and systolic 42 blood pressure were significantly observed in Ruminococcus and Prevotella 43 enterotypes, respectively. The present study indicates the possibility of 44 pathophysiological interplay between enterotypes and sleep structure disruption in 45 sleep apnea through a microbiota-gut-brain axis and offers some new insight toward 46 the pathogenesis of OSAHS. 47 obstructive sleep apnea/hypopnea syndrome 49 Importance 50 Intermittent hypoxia (IH) and sleep fragmentation (SF) are hallmarks of are the 51 predominant mechanism underlying obstructive sleep apnea/hypopnea syndrome 52 (OSAHS). Moreover, IH and SF of pathophysiological roles in the gut microbiota 53 dysbiosis in OSAHS have been demonstrated. We hypothesized that gut microbiota 54 disruption may cross-talk the brain function via microbiota-gut-brain axis. Indeed, 55 we observed central apnea indices and other parameters of disturbances during sleep 56 were significantly elevated in AHI≥15 patients with the Prevotella enterotype. This 57 enterotype prone to endotoxin production, driving systemic inflammation, ultimately 58 contributes to OSAHS-linked comorbidities. Vice versa, increasing the arousal index 59 leads to systemic inflammatory changes and accompanies metabolic dysfunction. We 60 highlight that the possibility that the microbiota-gut-brain axis operates a 61 bidirectional effect on the development of OSAHS pathology. Intermittent hypoxia (IH) and sleep fragmentation (SF) are hallmarks of 64 obstructive sleep apnea/hypopnea syndrome (OSAHS) [1-3]. IH plays a critical 65 pathophysiological role in of OSAHS, often accompanied by reduced oxygen 66 saturation, increased systemic pressure and bloodstream, excessive sympathetic neural 67 activity, impairment of autonomic function and apnea episodes end with an arousal of 68 the central nervous system (CNS), ultimately result in vascular endothelial 69 dysfunction and multi-organ morbid consequences. The underlying mechanism 70 involves inflammation and oxidative stress cascades [4,5]. 71 Contrastingly, sleep structure disruption is another risk factor for the 72 pathophysiology of OSAHS, causing major end-organ morbidity independent of IH 73 [6,7]. Repeated arousals disturbing different stages of sleep are the predominant 74 mechanism underlying OSAHS-induced brain injury wherein results from disruptions 75 of rapid eye movement (REM) and non-REM (NREM) [7]. Even disturbances in sleep 76 continuity are associated with emotional disorders [8]. SF promotes obesity and 77 metabolic abnormalities and may be mediated by concurrent alterations of the host gut 78 microbiota and concurrent systemic and adipose tissue inflammatory alterations 79 accompanied by insulin resistance [3,9]. Prolongation of the N1 stage and shortening 80 of REM times were observed in OSAHS-induced hypertension patients. Reportedly, 81 prolongation of the N1 sleep stage causes elevation of fasting blood glucose [10].
Introduction
intestinal epithelial barrier markers and increasing intestinal permeability, leading to local and systemic inflammatory responses and consequent multi-organ morbidities of pro-inflammatory IL-1β, IL-6, and TNF-α cytokines [23] . Furthermore, the rely on emotion and memory functions are also affected [8] . Moreover, the effects of 238 sleep deprivation on cognition have been investigated [32] . Thus, OSAHS patients 239 have been found to have neurocognitive and emotional disorders, suggesting the 240 modulation of various neurotransmitters during the sleep period [7] . Recently, a 241 multicenter randomized controlled trial has been initiated evaluating the extent to 242 which CPAP treatment improves neurocognitive dysfunction in OSAHS patients and 243 examining the role of gut microbiota in this change [11] . Preliminary results suggest 244 the viability of the hypothesis that microbiota modulate central nervous functions in 245 OSAHS patients. 246 Although the neural mechanisms underlying SAS-induced brain injury have not 247 been completely elucidated, repeated arousals enable the characterization of the 248 different stages of sleep. In the present study, the N1 sleep stage, MAD, and arousal 249 index were increased in Prevotella enterotype patients. BP was not significantly 250 different among the three enterotype AHI≥15 patient groups, but mean diastolic 251 pressure during sleep was >80 mmHg, which was similar to that observed in a 252 previous study [10] . MDA can act as an indicator of the levels of sleep parameters and 253 blood oxygenation for the evaluation of severe OSAHS patients [33] . When MAD is 254 elevated, sleep apnea appears to be more likely to cause respiratory arousal and might 255 impair sleep stability, resulting in SF. This outcome might then be that the transition 
